DK3237619T3 - Sammensætninger og fremgangsmåder til at inhibere ekspression af adamts-5 og adam17 - Google Patents
Sammensætninger og fremgangsmåder til at inhibere ekspression af adamts-5 og adam17 Download PDFInfo
- Publication number
- DK3237619T3 DK3237619T3 DK15872041.7T DK15872041T DK3237619T3 DK 3237619 T3 DK3237619 T3 DK 3237619T3 DK 15872041 T DK15872041 T DK 15872041T DK 3237619 T3 DK3237619 T3 DK 3237619T3
- Authority
- DK
- Denmark
- Prior art keywords
- adam17
- adamts
- procedures
- compositions
- inhibit expression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24014—Procollagen N-endopeptidase (3.4.24.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24082—ADAMTS-4 endopeptidase (3.4.24.82), i.e. aggrecanase 1
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410827650.3A CN104498498A (zh) | 2014-12-25 | 2014-12-25 | 抑制ADAM17基因的siRNA及其应用 |
CN201410828587.5A CN104560999B (zh) | 2014-12-25 | 2014-12-25 | 抑制ADAMTS‑5基因的siRNA及其应用 |
PCT/IB2015/002574 WO2016103042A1 (en) | 2014-12-25 | 2015-12-23 | Compositions and methods for inhibiting expression of adamts-5 and adam17 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3237619T3 true DK3237619T3 (da) | 2020-11-09 |
Family
ID=56149334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15872041.7T DK3237619T3 (da) | 2014-12-25 | 2015-12-23 | Sammensætninger og fremgangsmåder til at inhibere ekspression af adamts-5 og adam17 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10709729B2 (da) |
EP (1) | EP3237619B8 (da) |
JP (1) | JP6706628B2 (da) |
DK (1) | DK3237619T3 (da) |
ES (1) | ES2833028T3 (da) |
WO (1) | WO2016103042A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3058061A1 (fr) * | 2016-10-27 | 2018-05-04 | Selexel | Nouvelle utilisation d'oligonucleotides double brin |
CA3081823A1 (en) * | 2017-11-09 | 2019-05-16 | Ribomic Inc. | Aptamer for adamts5 and use for aptamer for adamts5 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2314691A3 (en) * | 2002-11-14 | 2012-01-18 | Dharmacon, Inc. | Fuctional and hyperfunctional siRNA |
US20060275794A1 (en) * | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
CN101238127A (zh) | 2005-05-20 | 2008-08-06 | 艾伦托斯制药控股公司 | 嘧啶或三嗪稠合的二环金属蛋白酶抑制剂 |
ES2413804T3 (es) | 2006-05-19 | 2013-07-17 | Alcon Research, Ltd. | Inhibición mediada por ARNi de estados relacionados con factor de necrosis tumoral-alfa |
WO2008109105A2 (en) * | 2007-03-06 | 2008-09-12 | Flagship Ventures | Methods and compositions for improved therapeutic effects with sirna |
AR067786A1 (es) * | 2007-08-03 | 2009-10-21 | Alcon Mfg Ltd | Inhibicion relacionada con arni (arn de interferencia) de senales tnfalfa (factor de necrosis tumoral) para el tratamiento de glaucoma |
CN102181446B (zh) * | 2011-04-01 | 2013-01-23 | 广州市锐博生物科技有限公司 | 可防治流感病毒的siRNA及其表达载体和药用组合物 |
CN107904239B (zh) * | 2014-12-25 | 2020-11-27 | 广州市锐博生物科技有限公司 | 抑制ADAMTS-5基因的siRNA及其应用 |
CN104498498A (zh) * | 2014-12-25 | 2015-04-08 | 广州市锐博生物科技有限公司 | 抑制ADAM17基因的siRNA及其应用 |
CN104560997B (zh) * | 2014-12-25 | 2018-05-04 | 中国科学院广州生物医药与健康研究院 | 抑制ADAMTS-5和ADAM17基因的siRNA组合物及其应用 |
-
2015
- 2015-12-23 DK DK15872041.7T patent/DK3237619T3/da active
- 2015-12-23 US US15/539,671 patent/US10709729B2/en active Active
- 2015-12-23 WO PCT/IB2015/002574 patent/WO2016103042A1/en active Application Filing
- 2015-12-23 JP JP2017552533A patent/JP6706628B2/ja active Active
- 2015-12-23 ES ES15872041T patent/ES2833028T3/es active Active
- 2015-12-23 EP EP15872041.7A patent/EP3237619B8/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3237619B8 (en) | 2021-03-10 |
JP2018506991A (ja) | 2018-03-15 |
WO2016103042A8 (en) | 2017-05-11 |
EP3237619A4 (en) | 2018-09-12 |
ES2833028T3 (es) | 2021-06-14 |
JP6706628B2 (ja) | 2020-06-10 |
EP3237619B1 (en) | 2020-10-21 |
WO2016103042A1 (en) | 2016-06-30 |
US10709729B2 (en) | 2020-07-14 |
EP3237619A1 (en) | 2017-11-01 |
US20180250323A1 (en) | 2018-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
DK3261721T3 (da) | Anvendelse af pridopidin til forbedring af hukommelse | |
DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
DK3149045T3 (da) | Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt | |
DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
DK3224269T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
DK2961831T3 (da) | Sammensætninger og fremgangsmåder til immunterapi | |
DK2958588T3 (da) | Kombination af vaccination og hæmning af PD-1-reaktionsvejen | |
DK3484469T3 (da) | Sammensætninger og fremgangsmåder til potentiering af antimikrober | |
DK3151832T3 (da) | Fremgangsmåder til øgning af tonisk hæmning og behandling af sekundær søvnløshed | |
DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
DK3071215T3 (da) | Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension | |
DK3194564T3 (da) | Trichodermasammensætninger og anvendelsesfremgangsmåder | |
DK3089971T3 (da) | Forbindelser og fremgangsmåder til anvendelse | |
DK3142664T3 (da) | Sammensætninger og fremgangsmåder til behandling og diagnosticering af øjensygdomme | |
DK3394272T3 (da) | Sammensætninger og fremgangsmåder til effektiv målretning af transgener | |
DK3052628T3 (da) | Sammensætninger og fremgangsmåder til inhibering af ekspression af alas1-genet | |
DK3283210T3 (da) | Fremgangsmåde | |
DK3132009T3 (da) | Fremgangsmåde | |
DK3110446T3 (da) | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme | |
DK3237621T3 (da) | Varianter af human alpha-galactosidase |